Warrant conversion: 14 lakh shares allotted to promoter group firm Essix Biosciences
INDSWFTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.6 pts more than Nifty Microcap 250 and 1.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Ind-Swift Laboratories' Preferential Issue Committee on Oct 8, 2026 approved allotment of 14 lakh equity shares upon conversion of 14 lakh fully convertible warrants to promoter group firm Essix Biosciences. Warrants were originally issued on Sept 17, 2026 at Rs 196 per share. The promoter paid the balance 75 percent of Rs 147 per share, aggregating to about Rs 20.58 crore. Paid-up equity capital rose from Rs 86.71 crore to Rs 86.96 crore, with total shares now at about 8.70 crore.
Promoter group entity converted warrants into shares, increasing promoter holding. Capital base expands; no fresh external dilution beyond the promoter.